GLP-1 RECEPTOR AGONIST

Clinical trials for GLP-1 RECEPTOR AGONIST explained in plain language.

Never miss a new study

Get alerted when new GLP-1 RECEPTOR AGONIST trials appear

Sign up with your email to follow new studies for GLP-1 RECEPTOR AGONIST, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug aims to help patients shed pounds after failed weight-loss surgery

Disease control Recruiting now

This study tests a drug called efsubaglutide alfa to help people who are still obese six months after weight-loss surgery lose more weight. About 60 adults aged 18 to 55 with a BMI of 28 or higher will take the drug or a placebo. The main goal is to see how much weight they lose …

Matched conditions: GLP-1 RECEPTOR AGONIST

Phase: PHASE4 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control

Last updated Jun 27, 2026 09:00 UTC

GLP-1 RECEPTOR AGONIST

Get alerted when new GLP-1 RECEPTOR AGONIST trials appear

New drug aims to help patients shed pounds after failed weight-loss surgery